{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:09:38Z","timestamp":1760202578008,"version":"3.33.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[1989,10,1]],"date-time":"1989-10-01T00:00:00Z","timestamp":623203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1989,10,1]],"date-time":"1989-10-01T00:00:00Z","timestamp":623203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1989,10]]},"DOI":"10.1136\/ard.48.10.798","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"798-802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Fetal loss treatment in patients with antiphospholipid antibodies."],"prefix":"10.1016","volume":"48","author":[{"given":"J","family":"Ordi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Barquinero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Vilardell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Jordana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Selva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Genover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1172\/JCI109869","article-title":"Monoclonal immunoglobulin M coagulation inhibitor with phospholipid specificity: mechanism of a lupus anticoagulant","volume":"66","author":"Thiagarajan, P.; S, Shapiro S.; De Marco, L.","year":"1980","unstructured":"Thiagarajan P, Shapiro S S, De Marco L. Monoclonal immunoglobulin M coagulation inhibitor with phospholipid specificity: mechanism of a lupus anticoagulant. J Clin Invest 1980; 66: 397-405.","journal-title":"J Clin Invest"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/26.5.324","article-title":"Syndrome of the black swan","volume":"26","author":"N, Harris E.","year":"1987","unstructured":"Harris E N. Syndrome of the black swan. Br J Rheumatol 1987; 26: 324-6.","journal-title":"Br J Rheumatol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ajh.2830190308","article-title":"Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases","volume":"19","author":"A, Gastineau D.; F, Kazmier J.; L, Nichols W.; W, Bowie E.J.","year":"1985","unstructured":"Gastineau D A, Kazmier J F, Nichols W L, Bowie E J W. Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases. Am J Hematol 1985; 19: 265-75.","journal-title":"Am J Hematol"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archinte.1984.00350150102029","article-title":"Thromboembolism in patients with the lupus-type anticoagulant","volume":"144","author":"Elias, M.; Eldor, A.","year":"1984","unstructured":"Elias M, Eldor A. Thromboembolism in patients with the lupus-type anticoagulant. Arch Intern Med 1984; 144: 510-5.","journal-title":"Arch Intern Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/archinte.1985.00360080059007","article-title":"Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants","volume":"145","author":"I, Glueck H.; S, Kant K.; A, Weiss M.; E, Pollak V.; A, Miller M.; M, Coots","year":"1985","unstructured":"Glueck H I, Kant K S, Weiss M A, Pollak V E, Miller M A, Coots M. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. Arch Intern Med 1985; 145: 1389-95.","journal-title":"Arch Intern Med"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1471-0528.1984.tb05923.x","article-title":"Lupus anticoagulant in pregnancy","volume":"91","author":"F, Lubbe W.; S, Butler W.; J, Palmer S.; C, Liggins G.","year":"1984","unstructured":"Lubbe W F, Butler W S, Palmer S J, Liggins G C. Lupus anticoagulant in pregnancy. Br J Obstet Gynaecol 1984; 91: 357-63.","journal-title":"Br J Obstet Gynaecol"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJM198511213132104","article-title":"Obstetric complications associated with the lupus anticoagulant","volume":"313","author":"W, Branch D.; R, Scott J.; K, Kochenour N.; E, Hershgold","year":"1985","unstructured":"Branch D W, Scott J R, Kochenour N K, Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985; 313: 1322-6.","journal-title":"N Engl J Med"},{"key":"ref_8","first-page":"576","article-title":"Prednisone and maternal lupus anticoagulant","volume":"ii:","author":"Ordi-Ros, J.; Vilardell Tarres, M.; Vila Baucells, M.; J, Maired J.; T, Solano J.","year":"1983","unstructured":"Ordi-Ros J, Vilardell Tarres M, Vila Baucells M, Maired J J, Solano J T. Prednisone and maternal lupus anticoagulant. Lancet 1983; ii: 576-7.","journal-title":"Lancet"},{"key":"ref_9","article-title":"Low-dose aspirin in pregnancy","volume":"410","author":"G, M.; de Swiet M; A, Robertson; A, M.; E, Flloyd; F, Hawkins D.","year":"1988","unstructured":"Elder M G, de Swiet M, Robertson A, Elder M A, Flloyd E, Hawkins D F. Low-dose aspirin in pregnancy. Lancet 1988; i: 410.","journal-title":"Lancet"},{"key":"ref_10","first-page":"738","article-title":"Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 1985; 62","author":"Loizou, S.; D, McCrea J.; C, Rudge A.; Reynolds, R.; C, Boyle C.; N, Harris E.","unstructured":"Loizou S, McCrea J D, Rudge A C, Reynolds R, Boyle C C, Harris E N. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 1985; 62: 738-45."},{"key":"ref_11","first-page":"1271","article-title":"revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"M, Tan E.; S, Cohen A.; F, Fries J.","year":"1982","unstructured":"Tan E M, Cohen A S, Fries J F, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.","journal-title":"The"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1136\/bmj.287.6398.1021","article-title":"Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant","volume":"287","author":"L, Boey M.; B, Colaco C.; E, Gharavi A.; B, Elkin K.; S, Loizou; V, Hughes G.R.","year":"1983","unstructured":"Boey M L, Colaco C B, Gharavi A E, Elkin K B, Loizou S, Hughes G R V. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J 1983; 287: 1021-3.","journal-title":"Br Med J"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJM198507183130304","article-title":"Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus","volume":"313","author":"D, Lockshin M.; L, Druzin M.; S, Goei","year":"1985","unstructured":"Lockshin M D, Druzin M L, Goei S, et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985; 313: 152-6.","journal-title":"N Engl J Med"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0002-9378(16)32527-3","article-title":"Decidual vaseulopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant","volume":"142","year":"1982","unstructured":"De Wolf F, Carreras L 0, Moerman P, Vermylen J, Van Assehe A, Renaer M. Decidual vaseulopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Ain J Obstet Gynecol 1982; 142: 829-34.","journal-title":"Ain J Obstet Gynecol"},{"key":"ref_15","first-page":"366","article-title":"Possible relationship between lupus inhibitor and recurrent abortion in young women","volume":"ii:","author":"G, Firkin B.; A, Howard M.; N, Radford","year":"1980","unstructured":"Firkin B G, Howard M A, Radford N. Possible relationship between lupus inhibitor and recurrent abortion in young women. Lancet 1980; ii: 366.","journal-title":"Lancet"},{"key":"ref_16","first-page":"153","article-title":"Intrauterine death and circulating anticoagulant ('antithromboplastin')","author":"M, Nilsson I.; B, Astedt; U, Hedner; D, Berezin","year":"1975","unstructured":"Nilsson I M, Astedt B, Hedner U, Berezin D. Intrauterine death and circulating anticoagulant ('antithromboplastin'). Acta Med Scand 1975; 197: 153-9.","journal-title":"Acta Med Scand"},{"key":"ref_17","first-page":"228","article-title":"Lupus anticoagulant and pregnancy management","volume":"iii:","author":"G, Farquharson R.; F, Pearson J.; L, John","year":"1984","unstructured":"Farquharson R G, Pearson J F, John L. Lupus anticoagulant and pregnancy management. Lancet 1984; iii: 228-9.","journal-title":"Lancet"},{"key":"ref_18","first-page":"52","article-title":"Spontaneous recurrent fetal wastage and autoimmune abnormalities: a study of fourteen cases","volume":"39","author":"P, Clauvel J.; C, Tchobroutsky; F, Danon; L, Sultan Y.Intrator; C, Brouet J.","year":"1986","unstructured":"Clauvel J P, Tchobroutsky C, Danon F, Sultan Y. Intrator L, Brouet J C. Spontaneous recurrent fetal wastage and autoimmune abnormalities: a study of fourteen cases. Clin Immuniol Immunopathol 1986; 39: 52-3-30.","journal-title":"Clin Immuniol Immunopathol"},{"key":"ref_19","first-page":"207","article-title":"Fetal loss in systemic lupus: association with anticardiolipin antibodies","volume":"2","author":"L, Derue G.; J, Englert H.; N, Harris E.; V, Hlughes G.R.","year":"1985","unstructured":"Derue G L, Englert H J, Harris E N, Hlughes G R V. Fetal loss in systemic lupus: association with anticardiolipin antibodies. J Obstet Gynecol 1985; 2: 207-9.","journal-title":"J Obstet Gynecol"},{"issue":"146","key":"ref_20","first-page":"2153","article-title":"Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test","volume":"1986","author":"N, Harris E.; W, Chan J.K.; A, Asherson R.; R, Aber V.; E, Gharavi A.; R, Hughes G.","unstructured":"Harris E N, Chan J K W, Asherson R A, Aber V R, Gharavi A E, Hughes G R. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Internt Med 1986: 146: 2153-6.","journal-title":"Arch Internt Med"},{"key":"ref_21","first-page":"265","article-title":"Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases","volume":"19","author":"J, Gastineau D.A.Kazmier F.; Z, Nichols W.; W, Bowie F.J.","year":"1985","unstructured":"Gastineau D A. Kazmier F J, Nichols W Z, Bowie F J W. Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases. Ain J Hemiiatol 1985; 19: 265-75.","journal-title":"Ain J Hemiiatol"},{"key":"ref_22","first-page":"859","article-title":"Avertements ai repetition, thromboses et anticoagulant circulant antithromboplastine","volume":"9","author":"P, Soulier R.; C, Boffa M.","year":"1980","unstructured":"Soulier R P, Boffa M C. Avertements ai repetition, thromboses et anticoagulant circulant antithromboplastine. La Nouvelle Presse Medicale 1980; 9: 859-64.","journal-title":"La Nouvelle Presse Medicale"},{"key":"ref_23","first-page":"550","article-title":"The relationship between lupus anticoagulants aind antibodies to phospholipid. JA","volume":"259","author":"A, Triplett D.; A, Brandt J.T.Musgrave K.; A, Orr C.","year":"1988","unstructured":"Triplett D A, Brandt J T. Musgrave K A, Orr C A. The relationship between lupus anticoagulants aind antibodies to phospholipid. JA MA 1988; 259: 550-4."},{"article-title":"Anticardiolipin antibodies in patients with lupus anticoagulants without systemic lupus erythematosus. Clini Exp Rheuinatol","author":"Ordi, J.; Barquinero, J.; MontalbAn, J.; Vilardell, Selva A.; M.","key":"ref_24","unstructured":"Ordi J, Barquinero J, MontalbAn J, Selva A. Vilardell M. Anticardiolipin antibodies in patients with lupus anticoagulants without systemic lupus erythematosus. Clini Exp Rheuinatol (in press)."},{"key":"ref_25","first-page":"742","volume":"ii:","author":"J, Lockwood C.; R, Reece E.A.Romero; liobbins J C","year":"1986","unstructured":"Lockwood C J, Reece E A. Romero R, liobbins J C. Antiphospholipid antibody and pregnancy wastage. Lancet 1986; ii: 742-3.","journal-title":"Antiphospholipid antibody and pregnancy wastage. Lancet"},{"key":"ref_26","first-page":"299","article-title":"Humlan thrombomodulin is inhibited by IgG from two patients with non-specific anticoagulants lAbstract]. Blood 1983: 62","volume":"1","author":"C, Comp P.; L, Esmon C.T.","year":"(suppl","unstructured":"Comp P C, DeBeault L E. Esmon N L, Esmon C T. Humlan thrombomodulin is inhibited by IgG from two patients with non-specific anticoagulants lAbstract]. Blood 1983: 62 (suppl 1): 299a."},{"key":"ref_27","first-page":"1193","article-title":"Inhibitionl of protein C activation by endothelial cells in the prescncc of the lupus anticoagulatnt","volume":"i:","author":"Cariou, R.; Caenl, Tobelemn G.Soria C.; J.","year":"1986","unstructured":"Cariou R, Tobelemn G. Soria C. Caenl J. Inhibitionl of protein C activation by endothelial cells in the prescncc of the lupus anticoagulatnt. Latcet 1986; i: 1193-4.","journal-title":"Latcet"},{"key":"ref_28","first-page":"3","article-title":"Lupus-like anticoagulants. modulation of the protein C pathwaly and thrombosis. Tlhrozib Hae, nost","volume":"55","author":"M, Freyssinet J.; P, Gazenave J.","year":"1986","unstructured":"Freyssinet J M, Gazenave J P. Lupus-like anticoagulants. modulation of the protein C pathwaly and thrombosis. Tlhrozib Hae,nost 1986; 55: 3(09-13."},{"key":"ref_29","first-page":"312","article-title":"Predisposing factors to thrombosis in systemic lupus erythemnatosus: possible relation to endothelial cell damage","volume":"94","author":"Y, Angles-Cano E.Clauvcl J.P.Sultan","year":"1979","unstructured":"Angles-Cano E. Clauvcl J P. Sultan Y. Predisposing factors to thrombosis in systemic lupus erythemnatosus: possible relation to endothelial cell damage. J Lab C\/inl Med 1979; 94: 312-23.","journal-title":"J Lab C\/inl Med"},{"key":"ref_30","first-page":"275","article-title":"Prekallikrein inhibition associated with the lupus anticoagulant: mechanism of thrombosis","volume":"77","author":"J, Sanfelippo M.; J, Drayna C.","year":"1982","unstructured":"Sanfelippo M J, Drayna C J. Prekallikrein inhibition associated with the lupus anticoagulant: mechanism of thrombosis. Ain J Clitt Pat\/ol 1982; 77: 275-9.","journal-title":"Ain J Clitt Pat\/ol"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM198410183111613","article-title":"Extremely-lowdose aspirin (one milligram per day) renders human platelets more sensitive to antiaggregation prostaglandins","volume":"311","author":"Sinzinger, H.; O'Grady, J.; Fitscha, P.; Kaliman, J.","year":"1984","unstructured":"Sinzinger H, O'Grady J, Fitscha P, Kaliman J. Extremely-lowdose aspirin (one milligram per day) renders human platelets more sensitive to antiaggregation prostaglandins. N Etgl J Med 1984; 311: 1052.","journal-title":"N Etgl J Med"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.0954-6820.1984.tb05010.x","article-title":"The lupus inhibitor in thrombocmbolic discasc and intrauterinc death in the absence of systcnic lupus","volume":"215","author":"Gardlund, B.","year":"1984","unstructured":"Gardlund B. The lupus inhibitor in thrombocmbolic discasc and intrauterinc death in the absence of systcnic lupus. Act Med Scatnd 1984; 215: 293-8.","journal-title":"Act Med Scatnd"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1471-0528.1986.tb07886.x","article-title":"Rccurrent abortion witlh lupus anticoagulant and prc-eclampsia: A common finial pathway for two different diseases'? Case rcport","volume":"93","author":"Gregorini, G.; Remuzzi, Setti G.; G.","year":"1986","unstructured":"Gregorini G, Setti G. Remuzzi G. Rccurrent abortion witlh lupus anticoagulant and prc-eclampsia: A common finial pathway for two different diseases'? Case rcport. Br J Obstet GYnaeco\/ 1986; 93: 194-6.","journal-title":"Br J Obstet GYnaeco\/"},{"key":"ref_34","first-page":"393","article-title":"Lupus anticoagulant and recurrcnt fetal loss: stuccessful treatmcnt with gammaglobulin","volume":"11","author":"Carreras L 0, Perez G N","year":"1988","unstructured":"Carreras L 0, Perez G N. Vega 11 R, Casavilla F. Lupus anticoagulant and recurrcnt fetal loss: stuccessful treatmcnt with gammaglobulin. Latcet 1988; ii: 393-4.","journal-title":"Vega"},{"key":"ref_35","first-page":"612","article-title":"Third International Antiphospholipid Confercncc: barbecucs, rum punches, and kaps. Annt1 Rhetin","volume":"47","author":"N, Harris E.","year":"1988","unstructured":"Harris E N. Third International Antiphospholipid Confercncc: barbecucs, rum punches, and kaps. Annt1 Rhetin Dis 1988; 47: 612-4.","journal-title":"Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724103834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724103834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.48.10.798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T07:51:09Z","timestamp":1737445869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724103834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1989,10]]}},"alternative-id":["S0003496724103834"],"URL":"https:\/\/doi.org\/10.1136\/ard.48.10.798","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[1989,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fetal loss treatment in patients with antiphospholipid antibodies.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.48.10.798","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1989 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}